Trade Alerts

Encorium Group Inc. (NASDAQ: $ENCO)

Encorium Group Inc. (NASDAQ: $ENCO) Encorium Group Inc. (ENCO) is a clinical research organization (CRO) engaged in the design and management of clinical trials for the pharmaceutical, biotechnology and medical device industries. The Company’s clients consist of companies in the pharmaceutical, biotechnology and medical device industries. The Company offers a range of clinical research and development services supporting Phase I - Continue Reading »

Anadys Pharmaceuticals Inc. (NASDAQ: $ANDS)

Anadys Pharmaceuticals Inc. (ANDS) is a biopharmaceutical company focused on developing medicines in the areas of hepatitis C and oncology. The Company is developing ANA598, a small-molecule, non-nucleoside inhibitor of the NS5B polymerase for the treatment of hepatitis C and ANA773, an oral Toll-like receptor 7 (TLR7) agonist prodrug for the treatment of hepatitis C and cancer. Both ANA598 and - Continue Reading »

Hemispherx Biopharma Inc. (AMEX: $HEB)

Hemispherx Biopharma Inc. (AMEX: $HEB) Hemispherx Biopharma Inc. (HEB) is a biopharmaceutical company engaged in the clinical development, manufacture, marketing and distribution of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. The Company’s products include Ampligen and Alferon N Injection. Ampligen is an experimental drug undergoing clinical development - Continue Reading »

OceanFreight Inc. (NASDAQ: $OCNF)(D*)

OceanFreight Inc. (NASDAQ: $OCNF)(D*) * Financial status indicator is deficient: Issuer failed to meet NASDAQ continued listing requirements. OceanFreight Inc. (OCNF) is a global provider of shipping transportation services. The Company specializes in transporting drybulk cargoes, including such commodities as iron ore, coal, grain and other materials and crude oil cargoes through the ownership and operation of nine drybulk carriers - Continue Reading »